Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Master Protocol for Phase 1 Clinical Trials of Multiple Amyloid-Targeting Therapies for the Treatment of Alzheimer's Disease

NCT07787169 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT07787169
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07787169 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Master Protocol for Phase 1 Clinical Trials of Multiple Amyloid-Targeting Therapies for the Treatment of Alzheimer's Disease
Lead sponsor
Eli Lilly and Company
Phase
Phase 1
Overall status
Recruiting
Start date
September 9, 2026
Completion date
July 31, 2028
Enrollment
179 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, amyloid, healthy volunteers, plaque, amyloid